Profile setting for Default Landing Page

Regorafenib Clinically Active in Ewing Sarcoma - Cancer Therapy Advisor

 
 
Cancer Therapy AdvisorRegorafenib Clinically Active in Ewing SarcomaCancer Therapy AdvisorSARC024 study met its primary endpoint for patients with Ewing sarcoma, and enrollment is ongoing for the liposarcoma and osteosarcoma cohorts. The following article features coverage from the 2017 American Society of Clinical Oncology (ASCO) Annual...
 
Related NewsFeeds

DOTmed.comNew hope for patients with severe lung diseaseScience DailyChronic Obstructive Pulmonary Disease (COPD) is an umbrella term used to describe progressive lung diseases including emphysema, ch

8 visits

Neurology AdvisorMechanical Thrombectomy Safe in Older Stroke PatientsNeurology AdvisorHealthDay News -- For older adults with acute ischemic stroke, endovascular therapy seems safe and efficacious, a

1 visits

SECcountry.comFormer Kentucky coach Guy Morriss reveals he's battling Alzheimer's DiseaseSECcountry.comFormer Kentucky coach Guy Morriss wasn't feeling himself last year. And there was a g

0 visits

Leadership NewspapersThe New Face Of NHISLeadership NewspapersThe major stakeholders of NHIS are the public and private service employees who are the direct beneficiaries of the scheme, the government

0 visits

Research and Markets - Radiation Oncology Market to Reach $10 Billion by 2025 - Key Vendors are Varian Medical ...PR Newswire (press release)North America held maximum share in global radiation oncolo

0 visits

Cancer Therapy AdvisorQ&A With Keith Flaherty, MD: Dabrafenib and Trametinib for MelanomaCancer Therapy AdvisorCancer Therapy Advisor interviewed study author Keith Flaherty, MD, director of the Henry

1 visits

Brownwood NewsBrown County Ag Extension: Keep Your Horse Vaccinations CurrentBrownwood NewsVaccinations are a vital part of health maintenance for your horse. They provide an active immunity to protec

0 visits

Medical XpressOnline pulmonary rehabilitation not inferior to face-to-face rehabMedical XpressOnline pulmonary rehabilitation for patients with chronic obstructive pulmonary disease (COPD) was found t

0 visits

Strata Oncology, Inc. Announces Launch of StrataNGS? TestPR Newswire (press release)ANN ARBOR, Mich., May 23, 2017 /PRNewswire/ -- Strata Oncology, Inc., a precision oncology company, today announced

0 visits

Pharmacist review of asthma patients is cost-effective, new study findsPharmacy Today, American Pharmacists Association, pharmacist.comA new study by U.K. researchers indicates that community pharmaci

1 visits

IMPT reduces second cancer risksMedical Physics Web (subscription)First developed at Karolinska, SBRT has been frequently employed by the hospital over the last two decades, Mondlane explains, but the

1 visits

Drug Discovery & DevelopmentNektar Therapeutics & Takeda Strike Research Parternship for Oncology CompoundsDrug Discovery & DevelopmentNektar Therapeutics (NASDAQ: NKTR) announced that Takeda and Nekt

0 visits

The Cerbat GemClovis Oncology (CLVS) Announces Presentations at 2017 ASCOStreetInsider.comClovis Oncology, Inc. (NASDAQ: CLVS) today announced that abstracts highlighting progress in the rucaparib cli

11 visits

The Daily DotGender confirmation surgeries shot up 19 percent last yearThe Daily Dot"Surgical therapy is one component of the overall care of the individual,? said Schechter. "It takes a team of exper

0 visits

Breast Cancer NewsMCLA-128 Helps Metastatic Breast Cancer Patients, First Results of Phase 1/2 Trial IndicateBreast Cancer NewsMerus' MCLA-128 antibody has helped patients with HER2-positive metas

9 visits

Ziarul Vocea ValciiAmendamentul deputatului de Vlcea, Eugen Nea?? a trecut: Romnii din zonele foarte poluate ies mai devreme la ...Ziarul Vocea ValciiDeputatul vlcean Eugen Nea?? aduce ve?ti bune p

8 visits

Are HMOs engaged in insurance business?Business MirrorAn HMO was first defined in 1995 through Republic Act 7875 (National Health Insurance Act of 1995), Section 4, (o), enumerating what health-care p

0 visits

RXi Pharmaceuticals to Present at the 3rd Annual Immuno-Oncology BD&L and Investment ForumPR Newswire (press release)MARLBOROUGH, Mass., May 23, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (N

0 visits

Skin cancer Mutational landscape of melanoma revealedNature.comMost cutaneous melanomas have a distinct, UV-radiation-induced mutational signature, which is dominated by C>T nucleotide transitions. Ho

0 visits

Haematological cancer Pembrolizumab is effective in multiple myelomaNature.comNewly published data from a phase II study involving patients with relapsed and/or refractory multiple myeloma (RRMM) indi

0 visits

 
Profile setting for Default Landing Page